In the past few weeks, from Pfizer to Moderna to AstraZeneca in Oxford, major progress has been made in the development of new crown vaccines and many good news have been heard, as if the era of the new crown epidemic is coming to an end. But it is worth noting that what is the name of the new crown vaccine and which company developed it. Eliminating the virus is the greatest effect, and it is also the key to the world's urgent need to develop a vaccine.
But research and development is only the first step. After the vaccine is on the market, pipeline, distribution and paving will be the follow-up points worthy of attention, especially the first two are extremely demanding on cold storage.
The Blockchain Department of the World Economic Forum had previously discussed how to distribute to achieve fairness, so the end of the blockchain was put on the agenda. Now, with the latest developments in pharmaceutical companies and researchers, Orbs co-founder Naita Colin has put forward his own views on how blockchain will benefit from "Global First".
Colin believes that blockchain "may be the perfect infrastructure for a supply chain management platform," because its lack of ownership and immutability cover the two prerequisites for establishing digital trust.
Because of the importance of temperature control-Pfizer’s vaccine requires a temperature of -70 degrees Celsius, and Moderna’s temperature is -20 degrees Celsius. The latter’s temperature requirements are relatively mild, but regardless of the temperature, distributors will be It is required to clearly prove that all storage conditions have been met. The World Economic Forum boldly declared that ensuring that stored data is recorded in an immutable database can "eliminate doubts about vaccine safety and effectiveness." The use case of the
vaccine can be extended to a wider supply chain, although it is part of a more general value. Manufacturers can track whether goods are delivered to their destinations on time, hospitals and clinics can better manage their inventory, and individuals can also provide the same guarantee for the specific vaccine they receive. The
World Economic Forum is not the only organization seeking such a solution. Earlier, Jason Kelley, general manager of IBM's blockchain services department, also mentioned temperature control issues.
Kelley wrote: "Unfortunately, this pandemic often indicates that our current supply chain may be under pressure, especially during times of crisis. To help gain an accurate view of inventory conditions and optimize vaccine allocation, stakeholders will A supply chain supported by advanced technologies such as artificial intelligence is needed to identify early warning signs of interruption from external data, optimize orders based on key needs, and manage inventory redistribution and prioritization."
"Distributors need to invest in'intelligence' The'supply chain' can provide near real-time supply of goods," Kelley added.
Colin uses her own company as an example. Her company is committed to providing supply chain solutions to make the traceability process clear. Z1z
Colin added: “Although it is not clear how long it will take to provide vaccines to each of us, the most certainty is that their supply chains must be closely monitored.”
